Medibio appoints experienced medical executive as new CEO

Medibio (ASX:MEB) has announced the appointment of Dr Thomas Young as its new CEO.

The company is developing mental health technology focused on the use of objective measures to aid in the early detection and screening of mental health conditions.

Dr Young has more than 40 years of medical experience. He is well-recognised in the fields of consumer-directed health care and behavioural health.

He was the co-founder of Nview Behavioral Health and currently serves as the chief medical officer and board member. Dr Young also serves as the medical director for Port of Hope, which is a non-profit substance use disorder clinic. Dr Young served for six years as the Medical Director of Idaho Medicaid and was also chief clinical and medical officer of Idaho Medicare QIO Qualis Health for nine years.

Medibio non-executive director Dr Matt Mesnik said, “We are excited to have Dr Young join Medibio as its CEO. Tom has a tremendous background in healthcare as a provider, administrator, innovator and leader. His background in mental health and mental health assessment is a tremendous asset toward the continued growth of the company.”

/Public Release. This material from the originating organization/author(s) may be of a point-in-time nature, edited for clarity, style and length. The views and opinions expressed are those of the author(s).View in full here.